# Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

> **NCT00006916** · PHASE2 · TERMINATED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 19 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **BIOLOGICAL:** bleomycin
- **DEVICE:** Ommaya reservoir
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00006916
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-06
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2020-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006916, "Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00006916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*